Skip to main content
Smart Investors Daily
FO

NASDAQ · FONR

FONAR Corporation

Healthcare · Medical - Devices

$19.09

Up+$0.00 (+0.00%)

Updated Sep 14, 2026, 2:01 PM

SID Score

5.7/10

Composite research score

Smart Money

Institutional and insider signal

Market cap
91.67M
P/E ratio
9.27
Dividend yield
0.00%
52-week range
$18.30 – $19.16
Volume
958.23K
Avg. volume
21.63K

Price performance

FONR price history

1M range · 0 trading sessions · Daily adjusted prices

FONR does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest FONR news

The latest Smart Investors Daily articles mentioning FONR.

FONR research

Overview

Company profile and research snapshot.

Company profile

Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
Implied upside
Analysts
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Feb 13, 2026

Fonar: Fiscal Q2 Earnings Snapshot

MELVILLE, N.Y. (AP) — Fonar Corp. FONR) on Friday reported earnings of $2.1 million in its fiscal second quarter. On a per-share basis, the Melville, New York-based company said it had net income of 31 cents.

Yahoo · Feb 13, 2026

Fonar Announces Financial Results for The 2nd Quarter of Fiscal 2026

Cash and cash equivalents decreased 6% to $53.0 million at December 31, 2025, as compared to $56.3 million for the fiscal year-ended June 30, 2025.Total Revenues - Net increased by 2% to $25.5 million for the quarter ended December 31, 2025, versus the corresponding quarter one year earlier. Total Revenues - Net increased by 3% to $51.6 million for the six-month period ended December 31, 2025, versus the corresponding six-month period one year earlier.Net Income increased 15% to $2.5 million for

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.